Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue
作者： Thomas Ernst , Manfred Hergenhahn , Marc Kenzelmann , Clemens D. Cohen , Mahnaz Bonrouhi
DOI: 10.1016/S0002-9440(10)61165-0
关键词: DNA microarray 、 Cancer 、 Pathology 、 Biology 、 Laser capture microdissection 、 PCA3 、 Gene expression 、 Phospholipase inhibitor 、 Prostate 、 Prostate cancer 、 Molecular biology
摘要: … prostate cancer, although elevated concentrations can also be found in benign prostatic hyperplasia … Histopathological diagnosis of prostate carcinoma is still regarded as the decisive …
elsevier.com
sci-hub.se 参考文章(34)
Rajal Shah, Neil R Mucci, Anita Amin, Jill A Macoska, Mark A Rubin, None, Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? American Journal of Pathology. ,vol. 158, pp. 1767- 1773 ,(2001) , 10.1016/S0002-9440(10)64132-6
Ritva Karhu, Jorma J. Isola, Olli-P. Kallioniemi, Anne H. Kallioniemi, Eija R. Hyytinen, Teuvo Tammela, Tapio Visakorpi, Ann-Christine Syvänen, Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization Cancer Research. ,vol. 55, pp. 342- 347 ,(1995)
Foster, Cornford, Forsyth, Djamgoz, Ke, The cellular and molecular basis of prostate cancer. BJUI. ,vol. 83, pp. 171- 194 ,(2001) , 10.1046/J.1464-410X.1999.00954.X
Lisa M. Sapinoso, Jessica Wang-Rodriguez, John B. Welsh, Christopher A. Moskaluk, Suzanne G. Kern, Andrew I. Su, Henry F. Frierson, Garret M. Hampton, Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Research. ,vol. 61, pp. 5974- 5978 ,(2001)
L Nordlund-Möller, J Lund, O Andersson, H J Barnes, Heterologous expression of human uteroglobin/polychlorinated biphenyl-binding protein. Determination of ligand binding parameters and mechanism of phospholipase A2 inhibition in vitro. Journal of Biological Chemistry. ,vol. 269, pp. 19081- 19087 ,(1994) , 10.1016/S0021-9258(17)32277-9
William J. Catalona, Torsten Ehrig, Jeffrey Milbrandt, Peter A. Humphrey, Jeffrey A. Magee, Lawrence True, Sushama Patil, Mark A. Watson, Toshiyuki Araki, Expression Profiling Reveals Hepsin Overexpression in Prostate Cancer Cancer Research. ,vol. 61, pp. 5692- 5696 ,(2001)
Janneke C. Alers, Pieter-Jaap Krijtenburg, André N. Vis, Robert F. Hoedemaeker, Mark F. Wildhagen, Wim C.J. Hop, Theodorus H. van der Kwast, Fritz H. Schröder, Hans J. Tanke, Herman van Dekken, Molecular Cytogenetic Analysis of Prostatic Adenocarcinomas from Screening Studies The American Journal of Pathology. ,vol. 158, pp. 399- 406 ,(2001) , 10.1016/S0002-9440(10)63983-1
Thomas A. Stamey, Biological determinants of cancer progression in men with prostate cancer. JAMA. ,vol. 281, pp. 1395- 1400 ,(1999) , 10.1001/JAMA.281.15.1395
Sacha Ferdinandusse, Simone Denis, Peter T. Clayton, Andrew Graham, John E. Rees, John T. Allen, Brendan N. McLean, Ann Y. Brown, Peter Vreken, Hans R. Waterham, Ronald J.A. Wanders, Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nature Genetics. ,vol. 24, pp. 188- 191 ,(2000) , 10.1038/72861
Warren D.W. Heston, Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: A novel folate hydrolase Urology. ,vol. 49, pp. 104- 112 ,(1997) , 10.1016/S0090-4295(97)00177-5